Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment

@article{Lassau2007DynamicCU,
  title={Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment},
  author={Nathalie Lassau and Linda Chami and Baya Benatsou and Pierre Peronneau and Alain Roche},
  journal={European Radiology Supplements},
  year={2007},
  volume={17},
  pages={89-98}
}
Dynamic contrast-enhanced ultrasonography (DCEUS) using the contrast agent Sonovue and vascular recognition imaging software is a novel technique that enables the detection of microvessels and quantitative assessment of solid tumor perfusion using raw linear data. Clinical trials have shown that DCE-US can be used to assess the anticancer efficacy of antiangiogenic treatment, for which conventional efficacy criteria based on size are unsuitable. Reduction in tumor vascularization can easily be… 
Standardization of Dynamic Contrast-Enhanced Ultrasound for the Evaluation of Antiangiogenic Therapies: The French Multicenter Support for Innovative and Expensive Techniques Study
TLDR
The standardization and dissemination of dynamic contrast-enhanced ultrasound (DCE-US) for the evaluation of antiangiogenic treatments in solid tumors across 19 oncology centers in France is described and a quality score is defined to account for the variability of the evaluation criteria used to collect DCE- US data.
Sonographic Assessment of Tumor Response: From In Vivo Models to Clinical Applications
TLDR
The principles and potential clinical applications of CEUS in determining tumor response and its promising role in enhancing medication delivery in certain tumors are discussed.
Validation of Dynamic Contrast-Enhanced Ultrasound in Predicting Outcomes of Antiangiogenic Therapy for Solid Tumors
TLDR
Dynamic contrast-enhanced ultrasound is a new functional imaging technique that provides a validated criterion, namely, the change of AUC from baseline to day 30, which is predictive of tumor progression in a large multicenter cohort.
Quantification of tumor vascularity with contrast-enhanced ultrasound for early response of transcatheter arterial chemoembolization for hepatocellular carcinoma: a report of three cases
TLDR
Early response of transcatheter arterial chemoembolization for hepatocellular carcinoma (HCC) is evaluated by quantitative analysis of intratumoral vascularity with CE-US in three patients by quantitatively indicating the early response of HCC to TACE.
Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.
TLDR
Dynamic US can be used to quantify dynamic changes in tumor vascularity as early as 3 days after bevacizumab administration in patients with HCC, and they may be potential surrogate measures of the effectiveness of antiangiogenic therapy in patientsWith HCC.
Perfusion CT and US of colorectal liver metastases : a correlative study of two dynamic imaging modalities
TLDR
DCE-US-based slope-value and tumour-to-liver perfusion gradient correlate best with DCE-CT perfusion values, however, both techniques cannot be used interchangeably.
The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib
TLDR
DCE-MRI, -CT and ultrasound produce complementary parameters that reflect the prognosis of patients receiving sunitinib for mRCC, and baseline vascular heterogeneity by DCE-US has the strongest prognostic value for PFS.
Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy
TLDR
The sharpened analysis of CEUS pixel intensity presented here strengthened the monitoring of breast tumor vasculature with the potential to improve the prediction of docetaxel efficacy.
Contrast-enhanced ultrasound: The evolving applications.
TLDR
The advent of CEUS has greatly enhanced the usefulness of US and even changed the status of US in clinical practice, and it is expected that its use will be expanded further in the future.
...
...

References

SHOWING 1-10 OF 20 REFERENCES
Dynamic contrast-enhanced Doppler ultrasound (DCE-US) is a useful radiological assessment to early predict the outcome of patients with gastrointestinal stromal tumors (GIST) treated with imatinib (IM).
TLDR
DCE-US is a new functional non invasive imaging technique that allows: 1) to predict after d7 the PFS 2) an early evaluation of secondary resistance to IM.
Evaluation of Contrast-Enhanced Color Doppler Ultrasound for the Quantification of Angiogenesis In Vivo
TLDR
Comparison of CDUS and digitized histological slide studies showed that the detection threshold after SHU 508A administration allowed visualization of small vessels, and the “hot spots” seen on histology were superimposable onto vessels seen with CDUS.
Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography.
TLDR
Contrast-enhanced Doppler sonography is a noninvasive imaging technique that allows the early prediction of tumor response in c-kit-positive GIST treated with Glivec.
Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.
TLDR
Quantification of intratumoral flow of a US contrast agent at gray-scale imaging shows promise for monitoring tumor vascular response to antiangiogenic therapy.
Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 cases.
TLDR
DUPC is a simple technique, allowing early prediction of tumour response after ILP, and a new treatment planning scheme can be proposed based on the results of this study.
Molecular imaging of antiangiogenic agents.
TLDR
The role of molecular imaging in general, and DCE-MRI in particular, in relation to treatment with antiangiogenic agents is discussed and some of the difficulties encountered are highlighted.
Effect of Angiosonography to Monitor Response During Imatinib Treatment in Patients with Metastatic Gastrointestinal Stromal Tumors
TLDR
Imatinib could induce antiangiogenic and/or antivascular effects in GIST, and this effect could be easily monitored with angiosonography, which might be a useful complement for monitoring the therapeutic effect of imatinib in these patients.
Science to practice: Will improved assessment of response to antiangiogenic therapies be achieved with contrast-enhanced gray-scale US?
TLDR
Contrast-enhanced gray-scale US, unlike power or color Doppler US performed without contrast enhancement, is better able to depict and distinguish microvascular flow in subcutaneously implanted mouse tumors possessing different vascular phenotypes.
Sorafenib (S) and dacarbazine (D) combination in patients (pts) with advanced malignant solid tumors: Phase I study with tumor biopsy genomic analysis and dynamic contrast enhanced ultrasonography (DCE-US)
TLDR
The pharmacokinetic (PK) profile of D ± S was defined, safety of the combination was assessed, and antitumor activity data was collected by genomic analysis and by DCE-US.
...
...